Skip to main content

NOUMED MOMETASONE HAYFEVER & ALLERGY RELIEF (NOUMED PHARMACEUTICALS PTY LTD)

Product name
NOUMED MOMETASONE HAYFEVER & ALLERGY RELIEF
Date registered
Evaluation commenced
Decision date
Approval time
171 (255 working days)
Active ingredients
mometasone furoate monohydrate
Registration type
New generic medicine
Indication

Noumed Mometasone Hayfever & Allergy Relief is indicated for the treatment of symptoms associated with seasonal allergic rhinitis and perennial allergic rhinitis and the prophylaxis of seasonal allergic rhinitis for up to 6 months in adults and children 12 years of age and over.

Help us improve the Therapeutic Goods Administration site